Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female Sprague-Dawley rats

Reproductive Toxicology

Volumn 54, Issue , 2015, Pages 110-119

  Manservisi, Fabiana ^a   Gopalakrishnan, Kalpana ^c   Tibaldi, Eva ^a   Hysi, Albana ^b   Iezzi, Manuela ^b   Lambertini, Luca ^c   Teitelbaum, Susan ^c   Chen, Jia ^c   Belpoggi, Fiorella ^a  

^a Cesare Maltoni Cancer Research Center Ramazzini Institute ^*  (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Endocrine disruptors; Mammary glands; Rats; Windows of susceptibility

Indexed keywords

ENDOCRINE DISRUPTOR; METHYL PARABEN; PHTHALIC ACID DIETHYL ESTER; TRANSCRIPTOME; TRICLOSAN; 4 HYDROXYBENZOIC ACID ESTER; PHTHALIC ACID DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; FEMALE; FEMALE FERTILITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HYPOTROPHY; INVOLUTION; LACTATION; LITTER SIZE; MAMMARY GLAND; MOLECULAR PATHOLOGY; MORPHOLOGY; MORTALITY; MULTIPARA; NEWBORN; NONHUMAN; NULLIPARA; PERINATAL PERIOD; PREGNANCY; PROGENY; RAT; REPRODUCTION; SURVIVAL; TRANSCRIPTOMICS; UPREGULATION; WEANING; ADVERSE EFFECTS; AGE; ANIMAL; DRUG EFFECTS; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; MATERNAL EXPOSURE; PATHOLOGY; PRENATAL EXPOSURE; PROCEDURES; SEXUAL DEVELOPMENT; SPRAGUE DAWLEY RAT; UDDER;

AGE FACTORS; ANIMALS; ENDOCRINE DISRUPTORS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; LACTATION; MAMMARY GLANDS, ANIMAL; MATERNAL EXPOSURE; PARABENS; PHTHALIC ACIDS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SEXUAL DEVELOPMENT; TRICLOSAN; WEANING;

EID: 84941316489     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2014.12.013     Document Type: Article

References (48)

1. World Health Organization (WHO) Global assessment of the state-of-the-science of endocrine, disruptors 2002, International Programme on Chemical Safety (IPCS).
2. Schug T.T., Janesick A., Blumberg B., Heindel J.J. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011, 127:204-215.
3. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009, 30:293-342.
4. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012, 33:378-455.
5. Brisken C. Endocrine disruptors and breast cancer. Chimia 2008, 62:406-409.
6. Macon M.B., Fenton S.E. Endocrine disruptors and the breast: early life effects and later life disease. J Mammary Gland Biol Neoplasia 2013, 18:43-61.
7. Fenton S.E. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 2006, 147:S18-S24.
8. Du K., Chu S., Xu X. Stimulation of MCF-7 cell proliferation by low concentrations of Chinese domestic polychlorinated biphenyls. J Toxicol Environ Health A 2000, 61:201-207.
9. Payne J., Rajapakse N., Wilkins M., Kortenkamp A. Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ Health Perspect 2000, 108:983-987.
10. Payne J., Scholze M., Kortenkamp A. Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environ Health Perspect 2001, 109:391-397.
11. Suzuki T., Ide K., Ishida M. Response of MCF-7 human breast cancer cells to some binary mixtures of oestrogenic compounds in-vitro. J Pharm Pharmacol 2001, 53:1549-1554.
12. Rider C.V., Furr J.R., Wilson V.S., Gray L.E. Cumulative effects of in utero administration of mixtures of reproductive toxicants that disrupt common target tissues via diverse mechanisms of toxicity. Int J Androl 2010, 33:443-462.
13. Hass U., Scholze M., Christiansen S., Dalgaard M., Vinggaard A.M., Axelstad M., et al. Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat. Environ Health Perspect 2007, 115(Suppl. 1):122-128.
14. Kelsey J.L., Gammon M.D., Jhon E.M. Reproductive factors and breast cancer. Epidemiol Rev 1993, 15:36-47.
15. Lanfranchi A. Normal breast physiology: the reasons hormonal contraceptives and induced abortion increase breast-cancer risk. Issues Law Med 2014, 29(Spring (1)):135-146.
16. Valentini A., Lubinski J., Byrski T., Ghadirian P., Moller P., Lynch H.T., et al. The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat 2013, 142(November (1)):177-185.
17. Shan L., He M., Yu M., Qiu C., Lee N.H., Liu E.T., et al. cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 2002, 23:1561-1568.
18. Chan M.M., Lu X., Merchant F.M., Iglehart J.D., Miron P.L. Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer. Carcinogenesis 2005, 26(8):1343-1353.
19. Decreto Legislativo Decreto Legislativo 116, 1992. Attuazione della direttiva. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici. Gazzetta Ufficiale 1992, (Suppl.):5-25. [in Italian].
20. Teitelbaum S, Lambertini L, Li Q, Belpoggi F, Falcioni L, Bua L, et al. Identification of endocrine disrupting chemical doses in rats to reproduce human urinary metabolite concentrations. Environment and Health - Bridging South, North, East and West. Basel, Switzerland 19-23 August, 2013 Oral presentation and ISEE Seattle Washington 24-28 August, 2014 Abstract number: 5107; ID: P-1-13-10.
21. Hvid H., Thorup I., Oleksiewicz M.B., Sjogren I., Jensen H.E. An alternative method for preparation of tissue sections from the rat mammary gland. Exp Toxicol Pathol 2011, 63:317-324.
22. Sholl D.A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 1953, 87:387-406.
23. Enoch R., Stanko J., Greiner S., Youngblood G., Rayner J., Fenton S.E. Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats. Environ Health Perspect 2007, 115(4):541-547.
24. von Heydebreck A., Huber W., Gentleman R. Differential expression with the bioconductor project. Encyclopedia of genetics, genomics, proteomics and bioinformatics 2004, John Wiley & Sons, Ltd.
25. Bourgon R., Gentleman R., Huber W. Independent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci U S A 2010, 107:9546-9551.
26. Gentleman R., Carey V., Huber W.F.H. Genefilter: methods for filtering genes from microarray experiments. R package 1.46.1 ed 2014.
27. Lemay D.G., Lynn D.J., Martin W.F., Neville M.C., Casey T.M., Rincon G., et al. The bovine lactation genome: insights into the evolution of mammalian milk. Genome Biol 2009, 10:R43.
28. White S.S., Calafat A.M., Kuklenyik Z., Villanueva L., Zehr R.D., Helfant L., et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 2007, 96:133-144.
29. Lemay D.G., Neville M.C., Rudolph M.C., Pollard K.S., German J.B. Gene regulatory networks in lactation: identification of global principles using bioinformatics. BMC Syst Biol 2007, 1:56.
30. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 1995, 57:289-300.
31. Warri A., Saarinen N.M., Makela S., Hilakivi-Clarke L. The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer 2008, 98:1485-1493.
32. Rudel R.A., Fenton S.E., Ackerman J.M., Euling S.Y., Makris S.L. Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations. Environ Health Perspect 2011, 119:1053-1061.
33. CDC (US Centers for Disease Control and Prevention) Fourth report on human exposure to environmental chemicals 2012.
34. Richert M.M., Schwertfeger K.L., Ryder J.W., Anderson S.M. An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 2000, 5(April (2)):227-241.
35. White S.S., Stanko J.P., Kato K., Calafat A.M., Hines E.P., Fenton S.E. Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ Health Perspect 2011, 119:1070-1076.
36. Latendresse J.R., Bucci T.J., Olson G., Mellick P., Weis C.C., Thorn B., et al. Genistein and ethinyl estradiol dietary exposure in multigenerational and chronic studies induce similar proliferative lesions in mammary gland of male Sprague-Dawley rats. Reprod Toxicol 2009, 28:342-353.
37. Kumar V., Chakraborty A., Kural M.R., Roy P. Alteration of testicular steroidogenesis and histopathology of reproductive system in male rats treated with triclosan. Reprod Toxicol 2009, 27:177-185.
38. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature 1990, 343:425-430.
39. Hidaka Y., Satoh T., Kamei T. Regulation of squalene epoxidase in HepG2 cells. J Lipid Res 1990, 31:2087-2094.
40. Clarenburg R., Chaikoff I.L. Origin of milk cholesterol in the rat: dietary versus endogenous sources. J Lipid Res 1966, 7:27-37.
41. Gibbons G.F., Pullinger C.R., Munday M.R., Williamson D.H. Regulation of cholesterol synthesis in the liver and mammary gland of the lactating rat. Biochem J 1983, 212:843-848.
42. Hachey D.L., Silber G.H., Wong W.W., Garza C. Human lactation. II: Endogenous fatty acid synthesis by the mammary gland. Pediatr Res 1989, 25:63-68.
43. Mohammad M.A., Haymond M.W. Regulation of lipid synthesis genes and milk fat production in human mammary epithelial cells during secretory activation. Am J Physiol Endocrinol Metab 2013, 305:E700-E716.
44. Lu S., Archer M.C. Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. Carcinogenesis 2005, 26:153-157.
45. Flavin R., Peluso S., Nguyen P.L., Loda M. Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol (Lond, Engl) 2010, 6:551-562.
46. Kelleher S.L., Velasquez V., Croxford T.P., McCormick N.H., Lopez V., MacDavid J. Mapping the zinc-transporting system in mammary cells: molecular analysis reveals a phenotype-dependent zinc-transporting network during lactation. J Cell Physiol 2012, 227:1761-1770.
47. Kelleher S.L., Lonnerdal B. Zn transporter levels and localization change throughout lactation in rat mammary gland and are regulated by Zn in mammary cells. J Nutr 2003, 133:3378-3385.
48. McCormick N.H., Kelleher S.L. ZnT4 provides zinc to zinc-dependent proteins in the trans-Golgi network critical for cell function and Zn export in mammary epithelial cells. Am J Physiol Cell Physiol 2012, 303:C291-C297.